Dr. Robert Joseph Rolfe Jr., MD

Dr. Rolfe practices at Duke University Hospital in Durham, North Carolina, part of Duke University.

Dr. Rolfe's NPI, 1790172443, was assigned on April 21, 2015. Dr. Rolfe holds North Carolina license 2021-03057.

Dr. Rolfe's primary practice is Duke University Hospital, at 2301 Erwin Rd, Durham, NC 27705 in Durham County. The practice phone is (919) 684-8111.

Dr. Rolfe's primary practice is Duke University Hospital in Durham, North Carolina, part of Duke University. Dr. Rolfe is also affiliated with Duke Regional Hospital. The medical group on file is Duke Health Integrated Practice. Dmand AI also links Dr. Rolfe to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rolfe practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Rolfe's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Rolfe is licensed in North Carolina.

CMS data shows 451 Medicare services from Dr. Rolfe across 8 procedure codes in 2024, for 188 Medicare patients. Medicare paid $34,707 for them.

CMS counts 188 Medicare patients who saw Dr. Rolfe in 2024. The largest group is 65 to 74, with 83 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rolfe's median patient age at 67, with 52% women.

In 2024, Dr. Rolfe wrote 608 Medicare Part D claims for 196 patients. 80% of them were for generic drugs. CMS names the drug for 455 of them, across 13 drugs with 11 or more claims each, at $215,191 in total drug cost. In 2023, CMS named 363 claims across 15 drugs.

Dr. Rolfe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rolfe as offering telehealth.

CMS Open Payments shows 1 general payment to Dr. Rolfe from 1 drug or device company in 2025. Consulting fees make up the largest share, 100% of the total. Bavarian Nordic A/S paid the most, $750.